Literature DB >> 20332124

Inflammatory and endothelial dysfunction markers and proteinuria in persons with type 1 diabetes mellitus.

Karine Sahakyan1, Barbara E K Klein, Kristine E Lee, Michael Y Tsai, Ronald Klein.   

Abstract

OBJECTIVE: We examined the relationship of inflammatory and endothelial dysfunction markers with the prevalence and incidence of gross proteinuria (GP) in persons with type 1 diabetes mellitus.
DESIGN: A longitudinal population-based cohort of persons with type 1 diabetes mellitus was followed from 1990-1992 through 2005-2007.
METHODS: Prevalence and 15-year cumulative incidence of GP were defined as outcome variables. Serum high-sensitivity C-reactive protein (hsCRP), interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-alpha), soluble vascular cell adhesion molecule-1 (VCAM-1), soluble intercellular adhesion molecule-1, and serum total homocysteine were measured. Multivariate logistic and discrete linear logistic regression modeling was used for data analysis.
RESULTS: After controlling for duration of diabetes and other confounding factors, TNF-alpha (odds ratio (OR) 3.64; 95% confidence interval (CI) 2.33, 5.70), IL-6 (OR 1.41; 95% CI 1.06, 1.88), VCAM-1 (OR 13.35; 95% CI 5.39, 33.07), and homocysteine (OR 2.98; 95% CI 1.73, 5.16) were associated with prevalent proteinuria. Only hsCRP (OR 1.47; 95% CI 1.02, 2.11) was associated with incident proteinuria.
CONCLUSIONS: These findings suggest a role of inflammation and endothelial dysfunction as markers and contributors of the development of diabetic nephropathy in persons with type 1 diabetes mellitus.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20332124      PMCID: PMC2921795          DOI: 10.1530/EJE-10-0049

Source DB:  PubMed          Journal:  Eur J Endocrinol        ISSN: 0804-4643            Impact factor:   6.664


  21 in total

1.  Hyperhomocyst(e)inemia and endothelial dysfunction in IDDM.

Authors:  M A Hofmann; B Kohl; M S Zumbach; V Borcea; A Bierhaus; M Henkels; J Amiral; A M Schmidt; W Fiehn; R Ziegler; P Wahl; P P Nawroth
Journal:  Diabetes Care       Date:  1998-05       Impact factor: 19.112

2.  The Wisconsin Epidemiologic Study of Diabetic Retinopathy. IX. Four-year incidence and progression of diabetic retinopathy when age at diagnosis is less than 30 years.

Authors:  R Klein; B E Klein; S E Moss; M D Davis; D L DeMets
Journal:  Arch Ophthalmol       Date:  1989-02

Review 3.  [Specifics of diabetic nephropathy, viewpoint in diabetology: trends of diabetic nephropathy in diabetes].

Authors:  Michel Krempf
Journal:  Nephrol Ther       Date:  2006-05       Impact factor: 0.722

Review 4.  Promotion, prediction and prevention of progression of nephropathy in type 1 diabetes mellitus.

Authors:  P Rossing
Journal:  Diabet Med       Date:  1998-11       Impact factor: 4.359

5.  Tubular staining of modified C-reactive protein in diabetic chronic kidney disease.

Authors:  Susanne B Schwedler; Frank Guderian; Jobst Dämmrich; Lawrence A Potempa; Christoph Wanner
Journal:  Nephrol Dial Transplant       Date:  2003-11       Impact factor: 5.992

Review 6.  Advanced glycation end products and diabetic complications.

Authors:  Alan W Stitt; Alicia J Jenkins; Mark E Cooper
Journal:  Expert Opin Investig Drugs       Date:  2002-09       Impact factor: 6.206

7.  Prevalence of diabetes mellitus in southern Wisconsin.

Authors:  R Klein; B E Klein; S E Moss; D L DeMets; I Kaufman; P S Voss
Journal:  Am J Epidemiol       Date:  1984-01       Impact factor: 4.897

8.  The Wisconsin epidemiologic study of diabetic retinopathy. II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years.

Authors:  R Klein; B E Klein; S E Moss; M D Davis; D L DeMets
Journal:  Arch Ophthalmol       Date:  1984-04

9.  The Wisconsin Epidemiologic Study of diabetic retinopathy. XIV. Ten-year incidence and progression of diabetic retinopathy.

Authors:  R Klein; B E Klein; S E Moss; K J Cruickshanks
Journal:  Arch Ophthalmol       Date:  1994-09

10.  Proteinuria is still useful for the screening and diagnosis of overt diabetic nephropathy.

Authors:  T Zelmanovitz; J L Gross; J Oliveira; M J de Azevedo
Journal:  Diabetes Care       Date:  1998-07       Impact factor: 19.112

View more
  8 in total

1.  An unusual presentation of atrial myxoma with haematuria and proteinuria.

Authors:  James R Bushnell; Charles Weston; Lazarus Karamadoukis
Journal:  NDT Plus       Date:  2011-01-21

2.  Effect of renal impairment on cognitive function during a 3-year follow up in elderly patients with type 2 diabetes: Association with microinflammation.

Authors:  Takahiko Kawamura; Toshitaka Umemura; Hiroyuki Umegaki; Rui Imamine; Naoko Kawano; Chiai Tanaka; Mariko Kawai; Makiko Minatoguchi; Minoru Kusama; Yu Kouchi; Atsuko Watarai; Akio Kanai; Eitaro Nakashima; Nigishi Hotta
Journal:  J Diabetes Investig       Date:  2014-02-04       Impact factor: 4.232

3.  Levels of Inflammatory Cytokines IL-1β, IL-6, IL-8, IL-17A, and TNF-α in Aqueous Humour of Patients with Diabetic Retinopathy.

Authors:  Songfu Feng; Honghua Yu; Ying Yu; Yu Geng; Dongli Li; Chun Yang; Qingjun Lv; Li Lu; Ting Liu; Guodong Li; Ling Yuan
Journal:  J Diabetes Res       Date:  2018-04-04       Impact factor: 4.011

Review 4.  Genetic and Biological Effects of ICAM-1 E469K Polymorphism in Diabetic Kidney Disease.

Authors:  Xiuli Zhang; Norhashimah Abu Seman; Henrik Falhammar; Kerstin Brismar; Harvest F Gu
Journal:  J Diabetes Res       Date:  2020-06-12       Impact factor: 4.011

5.  Biochemical and clinical markers of endothelial dysfunction do not outweigh traditional risk factors for the presence of diabetic retinopathy in patients with type 1 diabetes.

Authors:  Alessandra Saldanha de Mattos Matheus; Maria de Fátima Bevilacqua da Matta; Eliete Leão Silva Clemente; Maria de Lourdes Guimarães Rodrigues; Débora Cristina Torres Valença; Karla Rezende Guerra Drummond; Marília Brito Gomes
Journal:  Diabetol Metab Syndr       Date:  2022-09-27       Impact factor: 5.395

6.  Association of intercellular adhesion molecule 1 (ICAM1) with diabetes and diabetic nephropathy.

Authors:  Harvest F Gu; Jun Ma; Karolin T Gu; Kerstin Brismar
Journal:  Front Endocrinol (Lausanne)       Date:  2013-01-22       Impact factor: 5.555

7.  Association of Haemostatic and Inflammatory Biomarkers with Nephropathy in Type 1 Diabetes Mellitus.

Authors:  Caroline Pereira Domingueti; Rodrigo Bastos Fóscolo; Janice Sepúlveda Reis; Fernanda Magalhães Freire Campos; Luci Maria S Dusse; Maria das Graças Carvalho; Karina Braga Gomes; Ana Paula Fernandes
Journal:  J Diabetes Res       Date:  2015-12-06       Impact factor: 4.011

8.  Children with type 1 diabetes have elevated high-sensitivity C-reactive protein compared with a control group.

Authors:  Pilar Pérez-Segura; Olaya de Dios; Leticia Herrero; Claudia Vales-Villamarín; Isabel Aragón-Gómez; Teresa Gavela-Pérez; Carmen Garcés; Leandro Soriano-Guillén
Journal:  BMJ Open Diabetes Res Care       Date:  2020-07
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.